Establishment of a strategy system for the treatment of prostate cancer with Chinese medicine and its superiority research program
- Conditions
- prostate cancer
- Registration Number
- ITMCTR1900002649
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
(1) Comply with the diagnostic criteria for prostate adenocarcinoma and give endocrine therapy;
(2) Serum testosterone <50 ng / dl (1.7 nmol / L);
(3) The physical strength of the study subjects is normal, and the karnofsky score exceeds 60 points, and is expected to survive for more than half a year;
(4) Patient compliance is good and follow-up studies are possible;
(5) Understand and sign the informed consent form.
The above five conditions must be met at the same time.
(1) Patients with serious complications of prostate cancer;
(2) Allergic to endocrine therapy drugs;
(3) At the same time, it has obvious heart, brain and liver diseases;
(4) Patients with primary malignant tumors of organs other than prostate cancer;
(5) It is the end stage of the tumor, multiple organ failure.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PSA;therapeutic effect;
- Secondary Outcome Measures
Name Time Method blood biochemical indexes;Tumor markers;